We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Opioid Receptor

    Reference work entry 2024
  2. A µ-opioid receptor modulator that works cooperatively with naloxone

    The µ-opioid receptor (µOR) is a well-established target for analgesia 1 , yet conventional opioid receptor agonists cause serious adverse effects,...

    Evan S. O’Brien, Vipin Ashok Rangari, ... Brian K. Kobilka in Nature
    Article 03 July 2024
  3. µ-Opioid receptor antagonism facilitates the anxiolytic-like effect of oxytocin in mice

    Mood and anxiety disorders are leading causes of disability worldwide and are major contributors to the global burden of diseases. Neuropeptides,...

    Khalin E. Nisbett, Leandro F. Vendruscolo, George F. Koob in Translational Psychiatry
    Article Open access 28 February 2024
  4. The Kappa Opioid Receptor

    This book covers the latest knowledge in structure, signaling, and biochemical pharmacology of KOR as well as preclinical research and clinical...
    Lee-Yuan Liu-Chen, Saadet Inan in Handbook of Experimental Pharmacology
    Book 2022
  5. Ventral tegmental area glutamate neurons establish a mu-opioid receptor gated circuit to mesolimbic dopamine neurons and regulate opioid-seeking behavior

    A two-neuron model of ventral tegmental area (VTA) opioid function classically involves VTA GABA neuron regulation of VTA dopamine neurons via a mu -op...

    Dillon J. McGovern, Abigail M. Polter, ... David H. Root in Neuropsychopharmacology
    Article 05 July 2023
  6. Opioid antagonism in humans: a primer on optimal dose and timing for central mu-opioid receptor blockade

    Non-human animal studies outline precise mechanisms of central mu-opioid regulation of pain, stress, affiliation and reward processing. In humans,...

    Martin Trøstheim, Marie Eikemo, ... Siri Leknes in Neuropsychopharmacology
    Article Open access 17 August 2022
  7. Ptchd1 mediates opioid tolerance via cholesterol-dependent effects on μ-opioid receptor trafficking

    Repeated exposure to opioids causes tolerance, which limits their analgesic utility and contributes to overdose and abuse liability. However, the...

    Nycole Maza, Dandan Wang, ... Kirill A. Martemyanov in Nature Neuroscience
    Article 18 August 2022
  8. Profiling the proximal proteome of the activated μ-opioid receptor

    The μ-opioid receptor (μOR) represents an important target of therapeutic and abused drugs. So far, most understanding of μOR activity has focused on...

    Benjamin J. Polacco, Braden T. Lobingier, ... Ruth Hüttenhain in Nature Chemical Biology
    Article 25 March 2024
  9. Design and structural validation of peptide–drug conjugate ligands of the kappa-opioid receptor

    Despite the increasing number of GPCR structures and recent advances in peptide design, the development of efficient technologies allowing rational...

    Edin Muratspahić, Kristine Deibler, ... Christian W. Gruber in Nature Communications
    Article Open access 06 December 2023
  10. Opioid Use Disorder

    Opioid use disorder (OUD) is a significant public health burden with the highest rates of prevalence in the United States. Adverse events from...
    Christina Spoleti, Gibson George, Padmapriya Marpuri in Treatment of Psychiatric Disorders Among Older Adults
    Chapter 2024
  11. In vivo photopharmacology with a caged mu opioid receptor agonist drives rapid changes in behavior

    Photoactivatable drugs and peptides can drive quantitative studies into receptor signaling with high spatiotemporal precision, yet few are compatible...

    **ang Ma, Desiree A. Johnson, ... Matthew R. Banghart in Nature Methods
    Article 27 March 2023
  12. Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone

    (R,S)-methadone ((R,S)-MTD) is a µ-opioid receptor (MOR) agonist comprised of (R)-MTD and (S)-MTD enantiomers. (S)-MTD is being developed as an...

    Marjorie R. Levinstein, Paulo A. De Oliveira, ... Michael Michaelides in Molecular Psychiatry
    Article 25 December 2023
  13. Ligand efficacy modulates conformational dynamics of the µ-opioid receptor

    The µ-opioid receptor (µOR) is an important target for pain management 1 and molecular understanding of drug action on µOR will facilitate the...

    Jiawei Zhao, Matthias Elgeti, ... Chunlai Chen in Nature
    Article Open access 10 April 2024
  14. Molecular mechanism of biased signaling at the kappa opioid receptor

    The κ-opioid receptor (KOR) has emerged as an attractive drug target for pain management without addiction, and biased signaling through particular...

    Amal El Daibani, Joseph M. Paggi, ... Tao Che in Nature Communications
    Article Open access 11 March 2023
  15. Effects of the novel selective κ-opioid receptor agonist NP-5497-KA on morphine-induced reward-related behaviors

    Opioid addiction and the opioid overdose epidemic are becoming more serious, and the development of therapeutic agents is essential for the...

    Soichiro Ide, Toshitake Hirai, ... Kazutaka Ikeda in Scientific Reports
    Article Open access 24 October 2023
  16. Off-target activity of NBOMes and NBOMe analogs at the µ opioid receptor

    New psychoactive substances (NPS) are introduced on the illicit drug market at a rapid pace. Their molecular targets are often inadequately...

    Marie H. Deventer, Mattias Persson, ... Christophe P. Stove in Archives of Toxicology
    Article 28 February 2023
  17. Ligand and G-protein selectivity in the κ-opioid receptor

    The κ-opioid receptor (KOR) represents a highly desirable therapeutic target for treating not only pain but also addiction and affective disorders 1 ....

    Jianming Han, **gying Zhang, ... Tao Che in Nature
    Article Open access 03 May 2023
  18. Opioid-induced neuroanatomical, microglial and behavioral changes are blocked by suvorexant without diminishing opioid analgesia

    Heroin use disorder in humans and chronic opioid administration to mice result in an increase in the number and a decrease in the size of detected...

    Ronald McGregor, Ming-Fung Wu, ... Jerome M. Siegel in Nature Mental Health
    Article 09 July 2024
  19. Solving opioid receptor structures

    Sarah Crunkhorn in Nature Reviews Drug Discovery
    Article 08 February 2023
  20. Targeting Peripheral μ-opioid Receptors or μ-opioid Receptor-Expressing Neurons Does not Prevent Morphine-induced Mechanical Allodynia and Anti-allodynic Tolerance

    The chronic use of morphine and other opioids is associated with opioid-induced hypersensitivity (OIH) and analgesic tolerance. Among the different...

    Feng Du, Guangjuan Yin, ... Longzhen Cheng in Neuroscience Bulletin
    Article 09 January 2023
Did you find what you were looking for? Share feedback.